IHS Chemical Week

Regions :: North America :: U.S.

Merck KGaA to invest in biosimilars, eyes pharma acquisitions

5:32 AM MDT | May 10, 2014 | Natasha Alperowicz

Merck KGaA (Darmstadt, Germany) plans to invest €100 million ($137.6 million) this year in biosimilars, a new business being developed by its Merck Serono unit. In addition, Merck is eyeing pharma acquisition opportunities, particularly in the United States, the world’s largest drugs market, following its recent $2.6-billion acquisition of AZ Electronic Materials. This news emerged on Friday during the company’s annual general meeting (AGM). “As part of ‘Fit for 2018’, the focus of the next two years will be on growth. We are...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa